Patient journey for hypertension and dyslipidemia in Saudi Arabia: highlighting the evidence gaps

ABSTRACT:

Background

In recent years, Saudi Arabia has witnessed staggering rates of hypertension and dyslipidemia-related cardiovascular (CV) deaths, overburdening the healthcare ecosystem of the country. Appropriate public health interventions can be devised through quantitative mapping of evidence. Identification of potential data gaps can prioritize future research needs and develop a ‘best-fit’ framework for patient-centric management of hypertension and dyslipidemia.

Methods

This review quantified data gaps in the prevalence and key epidemiological touchpoints of the patient journey including awareness, screening, diagnosis, treatment, adherence, and control in patients with hypertension and dyslipidemia in Saudi Arabia. Studies published in English between January 2010 and D

SUBMITTER: Amir A 

PROVIDER: S-EPMC10316580 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature